Logo image of CMLS

CUMULUS MEDIA INC-CL A (CMLS) Stock Fundamental Analysis

NASDAQ:CMLS - Nasdaq - US2310828015 - Common Stock - Currency: USD

0.189  -0.04 (-18.95%)

After market: 0.16 -0.03 (-15.34%)

Fundamental Rating

2

CMLS gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 97 industry peers in the Media industry. CMLS has a bad profitability rating. Also its financial health evaluation is rather negative. CMLS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

CMLS had negative earnings in the past year.
In the past year CMLS has reported a negative cash flow from operations.
In multiple years CMLS reported negative net income over the last 5 years.
Of the past 5 years CMLS 4 years had a positive operating cash flow.
CMLS Yearly Net Income VS EBIT VS OCF VS FCFCMLS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M

1.2 Ratios

CMLS has a worse Return On Assets (-25.32%) than 78.35% of its industry peers.
Looking at the Return On Equity, with a value of -4075.01%, CMLS is doing worse than 81.44% of the companies in the same industry.
CMLS has a worse Return On Invested Capital (0.01%) than 63.92% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CMLS is significantly below the industry average of 7.56%.
Industry RankSector Rank
ROA -25.32%
ROE -4075.01%
ROIC 0.01%
ROA(3y)-10.83%
ROA(5y)-6.94%
ROE(3y)-1370.73%
ROE(5y)-824.61%
ROIC(3y)2.36%
ROIC(5y)2.14%
CMLS Yearly ROA, ROE, ROICCMLS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K -4K

1.3 Margins

CMLS has a worse Operating Margin (0.01%) than 63.92% of its industry peers.
In the last couple of years the Operating Margin of CMLS has declined.
The Gross Margin of CMLS (60.80%) is better than 74.23% of its industry peers.
In the last couple of years the Gross Margin of CMLS has remained more or less at the same level.
Industry RankSector Rank
OM 0.01%
PM (TTM) N/A
GM 60.8%
OM growth 3Y-89.25%
OM growth 5Y-76.27%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.04%
GM growth 5Y-0.89%
CMLS Yearly Profit, Operating, Gross MarginsCMLS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

2

2. Health

2.1 Basic Checks

CMLS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for CMLS has been increased compared to 1 year ago.
CMLS has less shares outstanding than it did 5 years ago.
The debt/assets ratio for CMLS is higher compared to a year ago.
CMLS Yearly Shares OutstandingCMLS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
CMLS Yearly Total Debt VS Total AssetsCMLS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

CMLS has an Altman-Z score of 0.48. This is a bad value and indicates that CMLS is not financially healthy and even has some risk of bankruptcy.
CMLS has a worse Altman-Z score (0.48) than 63.92% of its industry peers.
A Debt/Equity ratio of 96.41 is on the high side and indicates that CMLS has dependencies on debt financing.
CMLS has a Debt to Equity ratio of 96.41. This is amonst the worse of the industry: CMLS underperforms 81.44% of its industry peers.
Industry RankSector Rank
Debt/Equity 96.41
Debt/FCF N/A
Altman-Z 0.48
ROIC/WACC0
WACC8.05%
CMLS Yearly LT Debt VS Equity VS FCFCMLS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

CMLS has a Current Ratio of 1.85. This is a normal value and indicates that CMLS is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.85, CMLS is doing good in the industry, outperforming 63.92% of the companies in the same industry.
CMLS has a Quick Ratio of 1.85. This is a normal value and indicates that CMLS is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.85, CMLS is doing good in the industry, outperforming 63.92% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.85
Quick Ratio 1.85
CMLS Yearly Current Assets VS Current LiabilitesCMLS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

2

3. Growth

3.1 Past

CMLS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -65.57%.
The Revenue has decreased by -2.07% in the past year.
Measured over the past years, CMLS shows a decrease in Revenue. The Revenue has been decreasing by -5.77% on average per year.
EPS 1Y (TTM)-65.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-121.18%
Revenue 1Y (TTM)-2.07%
Revenue growth 3Y-3.36%
Revenue growth 5Y-5.77%
Sales Q2Q%-6.35%

3.2 Future

CMLS is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.18% yearly.
The Revenue is expected to grow by 0.60% on average over the next years.
EPS Next Y3.11%
EPS Next 2Y15.1%
EPS Next 3Y7.18%
EPS Next 5YN/A
Revenue Next Year-8.62%
Revenue Next 2Y-2.1%
Revenue Next 3Y-1.18%
Revenue Next 5Y0.6%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CMLS Yearly Revenue VS EstimatesCMLS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
CMLS Yearly EPS VS EstimatesCMLS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 10 -10 20 30

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CMLS. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CMLS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CMLS Price Earnings VS Forward Price EarningsCMLS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

CMLS's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.3
CMLS Per share dataCMLS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.1%
EPS Next 3Y7.18%

More info and screens

0

5. Dividend

5.1 Amount

CMLS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CUMULUS MEDIA INC-CL A

NASDAQ:CMLS (5/1/2025, 8:53:06 PM)

After market: 0.16 -0.03 (-15.34%)

0.189

-0.04 (-18.95%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)05-01 2025-05-01/bmo
Earnings (Next)07-31 2025-07-31/bmo
Inst Owners40.09%
Inst Owner Change0%
Ins Owners10.97%
Ins Owner Change0%
Market Cap3.30M
Analysts45.71
Price Target11.22 (5836.51%)
Short Float %0.77%
Short Ratio0.19
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)11.38%
Min EPS beat(2)-10.75%
Max EPS beat(2)33.5%
EPS beat(4)2
Avg EPS beat(4)-42.91%
Min EPS beat(4)-231.51%
Max EPS beat(4)37.11%
EPS beat(8)4
Avg EPS beat(8)-21.47%
EPS beat(12)5
Avg EPS beat(12)-17.82%
EPS beat(16)8
Avg EPS beat(16)-20.84%
Revenue beat(2)0
Avg Revenue beat(2)-2.17%
Min Revenue beat(2)-2.28%
Max Revenue beat(2)-2.06%
Revenue beat(4)0
Avg Revenue beat(4)-2.23%
Min Revenue beat(4)-2.51%
Max Revenue beat(4)-2.06%
Revenue beat(8)0
Avg Revenue beat(8)-1.8%
Revenue beat(12)2
Avg Revenue beat(12)-0.91%
Revenue beat(16)3
Avg Revenue beat(16)-0.79%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-3.2%
EPS NQ rev (3m)-10.26%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.31%
Revenue NQ rev (1m)0.15%
Revenue NQ rev (3m)-4.57%
Revenue NY rev (1m)-5.3%
Revenue NY rev (3m)-7.35%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0
P/FCF N/A
P/OCF N/A
P/B 0.47
P/tB N/A
EV/EBITDA 10.3
EPS(TTM)-4.52
EYN/A
EPS(NY)-2.36
Fwd EYN/A
FCF(TTM)-1.29
FCFYN/A
OCF(TTM)-0.18
OCFYN/A
SpS47.42
BVpS0.4
TBVpS-33.73
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -25.32%
ROE -4075.01%
ROCE 0.01%
ROIC 0.01%
ROICexc 0.01%
ROICexgc 0.02%
OM 0.01%
PM (TTM) N/A
GM 60.8%
FCFM N/A
ROA(3y)-10.83%
ROA(5y)-6.94%
ROE(3y)-1370.73%
ROE(5y)-824.61%
ROIC(3y)2.36%
ROIC(5y)2.14%
ROICexc(3y)2.54%
ROICexc(5y)2.34%
ROICexgc(3y)8%
ROICexgc(5y)7.4%
ROCE(3y)2.99%
ROCE(5y)2.71%
ROICexcg growth 3Y-88.54%
ROICexcg growth 5Y-74.64%
ROICexc growth 3Y-88.06%
ROICexc growth 5Y-75.01%
OM growth 3Y-89.25%
OM growth 5Y-76.27%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.04%
GM growth 5Y-0.89%
F-Score3
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 96.41
Debt/FCF N/A
Debt/EBITDA 11.32
Cap/Depr 32.92%
Cap/Sales 2.35%
Interest Coverage 0
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.85
Quick Ratio 1.85
Altman-Z 0.48
F-Score3
WACC8.05%
ROIC/WACC0
Cap/Depr(3y)43.63%
Cap/Depr(5y)45.37%
Cap/Sales(3y)2.85%
Cap/Sales(5y)2.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-65.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-121.18%
EPS Next Y3.11%
EPS Next 2Y15.1%
EPS Next 3Y7.18%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.07%
Revenue growth 3Y-3.36%
Revenue growth 5Y-5.77%
Sales Q2Q%-6.35%
Revenue Next Year-8.62%
Revenue Next 2Y-2.1%
Revenue Next 3Y-1.18%
Revenue Next 5Y0.6%
EBIT growth 1Y-99.71%
EBIT growth 3Y-89.62%
EBIT growth 5Y-77.64%
EBIT Next Year1480.77%
EBIT Next 3Y147.42%
EBIT Next 5Y86.44%
FCF growth 1Y-429.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-109.85%
OCF growth 3YN/A
OCF growth 5YN/A